This inventor holds 1 USPTO granted patent. Top assignee: Baxter International Inc.. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: Charles Jersild - Innovator in Drug Delivery Systems
Introduction
Charles Jersild is a notable inventor based in Vernon Hills, IL (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative designs and patents. His work focuses on improving the efficiency and effectiveness of drug administration methods.
Latest Patents
One of Charles Jersild's key patents is titled "Cannula for use in drug delivery systems and systems including same." This invention provides an improved cannula designed to reconstitute powdered drugs within a drug delivery system. The cannula features a closed first end with a member for piercing a septum, and it includes at least two slots that allow fluid communication between the channel and the exterior. This design ensures that the slots have a minimum projected area equal to or greater than the cross-sectional area of the channel, enhancing the functionality of the device. Charles Jersild holds 1 patent related to this innovative technology.
Career Highlights
Charles Jersild is associated with Baxter International Inc., a leading company in the healthcare sector. His work at Baxter has allowed him to contribute to advancements in medical technology, particularly in drug delivery systems. His innovative approach has positioned him as a valuable asset in the field.
Collaborations
Throughout his career, Charles has collaborated with notable colleagues, including Joseph A Bancsi and Charles Eller. These collaborations have fostered an environment of innovation and have led to the development of cutting-edge medical solutions.
Conclusion
Charles Jersild's contributions to drug delivery systems exemplify the impact of innovation in healthcare. His patent for an improved cannula demonstrates his commitment to enhancing medical technology. His work continues to influence the field and improve patient outcomes.
